GnRH Agonist Treatment before Total Laparoscopic Hysterectomy for Large Uteri

This publication has 14 references indexed in Scilit:

• Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial
  BJOG: An International Journal of Obstetrics and Gynaecology, 1998
• Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma
  Acta Obstetricia et Gynecologica Scandinavica, 1995
• Treatment with the gonadotrophin releasing hormone‐agonist goserelin before hysterectomy for uterine fibroids
  BJOG: An International Journal of Obstetrics and Gynaecology, 1994
• Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas
  Acta Obstetricia et Gynecologica Scandinavica, 1993
• A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri
  Journal of Clinical Endocrinology & Metabolism, 1993
• A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas
  American Journal of Obstetrics and Gynecology, 1991
• Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women
  Fertility and Sterility, 1991
• Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelin
  BJOG: An International Journal of Obstetrics and Gynaecology, 1989
• GOSERELIN THERAPY BEFORE SURGERY FOR UTERINE FIBROIDS
  The Lancet, 1987
• A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogue
  American Journal of Obstetrics and Gynecology, 1983